Effect of HIIT Exercises with Thyme Supplement on Plasma Lipoproteins and Liver Enzymes of Men with Fatty Liver: A Semi-experimental Study

Document Type : Original article

Authors

1 MSc, Department of Sports Physiology, Faculty of Sport Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran

2 Associate Professor, Department of Sports Physiology, Faculty of Sport Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran

Abstract

Introduction: Fatty liver is a type of fat accumulation in liver cells that causing a malignant process leading to the fibrosis of the liver tissue and cellular destruction if left unchecked. The present study aimed to investigate the effect of HIIT exercises with thyme supplement on the plasma lipoproteins and liver enzymes of male patients with fatty liver.
Materials and Methods: The present semi-experimental study was carried out on 40 men with fatty liver who were randomly divided into four groups of HIIT exercises and thyme supplement, HIIT exercises and placebo, thyme supplement, and control. The supplement groups received a 2-g capsule daily for 2 weeks. In addition, the placebo group received a 1-g starch capsule in two meals (i.e., lunch and dinner) for 2 weeks. The subjects performed a researcher-made HIIT training protocol in six sessions for 2 weeks. The results were analyzed using covariance analysis and paired t-test. The significance level was considered to be P ≤ 0.05.
Results: The results of statistical analysis showed that the plasma concentrations of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, and total cholesterol, triglycerides, and low-density lipoprotein enzymes had a significant decrease after 2 weeks of HIIT exercises with thyme supplement (P≤0.05). The obtained findings also showed that high-density lipoprotein was reported with a significant increase after 2 weeks of HIIT exercises with thyme supplement (P≤0.05).
Conclusion: The results of this study demonstrated that HIIT exercises with thyme supplement affect liver enzymes and plasma lipids

Keywords

References

  1. McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol. 2002; 34(3):255-62.
  2. McClain CJ, Mokshagundam SP, Barve SS, Song Z, Hill DB, Chen T, et al. Mechanisms of non-alcoholic steatohepatitis. Alcohol. 2004; 34(1):67-79.
  3. Petta S, Muratore C, Craxì A. Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig Liver Dis. 2009; 41(9):615-25.
  4. Bellentani S. The epidemiology of non-alcoholic fatty liver disease. Liver Int. 2017; 37(Suppl 1):81-4.
  5. Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med. 2013; 16(10):584-9.
  6. Lankarani KB, Ghaffarpasand F, Mahmoodi M, Lotfi M, Zamiri N, Heydari ST, et al. Non alcoholic fatty liver disease in southern Iran: a population based study. Hepat Mon. 2013; 13(5):e9248.
  7. Mirnasouri R, Rahmati M. The effect of eight weeks of aerobic training on the levels of enzymes associated with non-alcoholic fatty liver in obese children. Yafteh. 2018; 20(2):53-61. [in Persian]
  8. Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017; 9(16):715-32.
  9. Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018; 67(1):328-57.
  10. Cantero I, Abete I, Monreal JI, Martinez JA, Zulet MA. Fruit fiber consumption specifically improves liver health status in obese subjects under energy restriction. Nutrients. 2017; 9(7):667.
  11. Wang Q, Zheng D, Liu J, Fang L, Li Q. Atherogenic index of plasma is a novel predictor of non-alcoholic fatty liver disease in obese participants: a cross-sectional study. Lipids Health Dis. 2018; 17(1):284.
  12. Xie DY, Fan HK, Ren ZG, Fan J, Gao Q. Identifying clonal origin of multifocal hepatocellular carcinoma and its clinical implications. Clin Transl Gastroenterol. 2019; 10(2):e00006.
  13. Feldman A, Eder SK, Felder TK, Kedenko L, Paulweber B, Stadlmayr A, et al. Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver. Am J Gastroenterol. 2017; 112(1):102-10.
  14. Marin-Alejandre BA, Abete I, Cantero I, Riezu-Boj JI, Milagro FI, Monreal JI, et al. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: a comparison with healthy controls. Nutrients. 2019; 11(2):322.
  15. Marin-Alejandre BA, Abete I, Cantero I, Monreal JI, Elorz M, Herrero JI, et al. The metabolic and hepatic impact of two personalized dietary strategies in subjects with obesity and nonalcoholic fatty liver disease: the fatty liver in obesity (FLiO) randomized controlled trial. Nutrients. 2019; 11(10):2543.
  16. Nasri S, Kerishchi Khiabani P. The effects of romarinus officinalis leaf hydroalcoholic extract on histopathology and enzymes activity of liver in alloxan induced diabetic rats. Iran J Diabetes Metab. 2018; 17(4):189-97. [in Persian]
  17. Soleimani A, Shakerian S, Ranjbar R. Changes in liver enzymes after the implementation of astrand and rast tests in overweight individuals. J Adv Med Biomed Res. 2019; 27(121):1-7.
  18. Kessler HS, Sisson SB, Short KR. The potential for high-intensity interval training to reduce cardiometabolic disease risk. Sports Med. 2012; 42(6):489-509.
  19. Ghasemi E, Afzalpour ME, Zarban A. Effect of a 10 week high intensity interval training supplemented with green tea on lipid profiles and body composition in overweight women. J Birjand Univ Med Sci. 2016; 23(3):198-210. [in Persian]
  20. Heydari M, Heydari H, Saadati A, Gharehbeglou M, Tafaroji J, Akbari A. Ethnomedicine for neonatal jaundice: a cross-sectional survey in Qom, Iran. J Ethnopharmacol. 2016; 193:637-42.
  21. Akbari A, Nasiri K, Heydari M, Mosavat SH, Iraji A. The protective effect of hydroalcoholic extract of zingiber officinale roscoe (Ginger) on ethanol-induced reproductive toxicity in male rats. J Evid Based Complementary Altern Med. 2017; 22(4):609-17.
  22. Afshar L, Mirazi N. Hepatoprotective effect of Zataria multiflora L. hydroethanolic extract in male rats treated by acetaminophen. Razi J Med Sci. 2019; 25(10):10-20. [in Persian]
  23. Mikami T, Sumida S, Ishibashi Y, Ohta S. Endurance exercise training inhibits activity of plasma GOT and liver caspase-3 of rats exposed to stress by induction of heat shock protein 70. J Appl Physiol. 2004; 96(5):1776-81.
  24. Kazemzadeh Y, Banaeifar A, Shirvani H, Gharaat A. The effect of high intensity interval training HIIT on body composition, lipid profile and insulin sensitivity in overweight young men. Physiol Sport Phys Activity. 2016; 9(2):1358-94. [in Persian]
  25. Parsa L, Ozgoli G, Mojab F, Nasiri M, Moramezi F, Ghezi M. Comparison of effects of Zataria multiflora capsule and Ibuprofen on postpartum pain. Iran J Obstet Gynecol Infertil. 2019; 22(3):32-40. [in Persian]
  26. Ertas A, Boga M, Yilmaz MA, Yesil Y, Tel G, Temel H, et al. A detailed study on the chemical and biological profiles of essential oil and methanol extract of Thymus nummularius (Anzer tea): Rosmarinic acid. Ind Crops Prod. 2015; 67:336-45.
  27. Soares JR, Dinis TC, Cunha AP, Almeida LM. Antioxidant activities of some extracts of Thymus zygis. Free Radic Res. 1997; 26(5):469-78.
  28. Roby MH, Sarhan MA, Selim KA, Khalel KI. Evaluation of antioxidant activity, total phenols and phenolic compounds in thyme (Thymus vulgaris L.), sage (Salvia officinalis L.), and marjoram (Origanum majorana L.) extracts. Ind Crops Prod. 2013; 43:827-31.
  29. Ahmadipour A, Sharififar F, Najafi A, Atashbar J, Karami-Mohajeri S. Preventive effect of methanolic extract of Zataria Multiflora Boiss on liver toxicity of paracetamol in rats. J Med Life. 2015; 8(4):270.
  30. Ahmadipour A, Sharififar F, Nakhaipour F, Samanian M, Karami-Mohajeri S. Hepatoprotective effect of Zataria Multiflora Boisson cisplatin-induced oxidative stress in male rat. J Med Life. 2015; 8(4):275-81.
  31. de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, et al. Biochemical & nutritional profile of obese adolescent with non alcholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2007; 44(4):446-52.
  32. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol. 2006; 290(5):G852-8.
  33. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31.
  34. Booth F. Exercise prevents fatty liver. University of Missouri–Columbia. Lateest Sci Newslett. 2008; 29:14-5.
  35. Brandt LJ, Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's gastrointestinal and liver disease: pathophysiology, diagnosis, management. Pennsylvania: Saunders; 2006.
  36. Wilmore JH, Costill DL, Kenney WL. Physiology of sport and exercise. Champaign, IL: Human kinetics; 2015.
  37. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002; 51(6):1889-95.
  38. Asgary S, Kazemi S, Moshtaghian SJ, Rafieian-Kopaei M, Bahrami M, Adelnia A. The protective effect of Cucurbita pepo L. on liver damage in alloxan-induced diabetic rats. J Shahrekord Univ Med Sci. 2010; 11:59-65. [in Persian]
  39. Larson-Meyer DE, Newcomer BR, Heilbronn LK, Volaufova J, Smith SR, Alfonso AJ, et al. Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring). 2008; 16(6):1355-62.
  40. Davoodi M, Moosavi H, Nikbakht M. The effect of eight weeks selected aerobic exercise on liver parenchyma and liver enzymes (AST, ALT) of fat liver patients. J Shahrekord Univ Med Sci. 2012; 14(1):84-90. [in Persian]
Navid No
Volume 23, Issue 75
December 2020
Pages 51-61

Files

Share

How to cite

Statistics